

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neurotransmitter catabolic process (GO:0042135) | 9.70462400 |
| 2 | norepinephrine metabolic process (GO:0042415) | 9.43670450 |
| 3 | behavioral response to ethanol (GO:0048149) | 9.19886660 |
| 4 | cartilage morphogenesis (GO:0060536) | 9.10997871 |
| 5 | cardiac ventricle formation (GO:0003211) | 8.44754638 |
| 6 | catecholamine biosynthetic process (GO:0042423) | 8.33553206 |
| 7 | catechol-containing compound biosynthetic process (GO:0009713) | 8.33553206 |
| 8 | cell migration involved in heart development (GO:0060973) | 8.26254258 |
| 9 | dopamine metabolic process (GO:0042417) | 8.23310151 |
| 10 | peripheral nervous system neuron development (GO:0048935) | 7.27357307 |
| 11 | synaptic transmission, cholinergic (GO:0007271) | 7.26693806 |
| 12 | maternal behavior (GO:0042711) | 7.09759560 |
| 13 | tongue development (GO:0043586) | 6.72370933 |
| 14 | response to water (GO:0009415) | 6.60733615 |
| 15 | parental behavior (GO:0060746) | 6.32756184 |
| 16 | catechol-containing compound metabolic process (GO:0009712) | 5.94922843 |
| 17 | catecholamine metabolic process (GO:0006584) | 5.94922843 |
| 18 | negative regulation of microtubule polymerization (GO:0031115) | 5.87185560 |
| 19 | cellular response to nicotine (GO:0071316) | 5.80832654 |
| 20 | dopamine biosynthetic process (GO:0042416) | 5.65908676 |
| 21 | alkaloid metabolic process (GO:0009820) | 5.65770490 |
| 22 | positive regulation of glomerulus development (GO:0090193) | 5.62484673 |
| 23 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 5.60824073 |
| 24 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 5.43681348 |
| 25 | negative regulation of dendrite morphogenesis (GO:0050774) | 5.41167026 |
| 26 | positive regulation of cell size (GO:0045793) | 5.40491179 |
| 27 | neuromuscular synaptic transmission (GO:0007274) | 5.34077579 |
| 28 | regulation of heart morphogenesis (GO:2000826) | 5.12748476 |
| 29 | cellular response to nerve growth factor stimulus (GO:1990090) | 5.10520949 |
| 30 | response to nerve growth factor (GO:1990089) | 5.10520949 |
| 31 | mesenchymal cell proliferation (GO:0010463) | 5.08640754 |
| 32 | neurotransmitter biosynthetic process (GO:0042136) | 4.97367757 |
| 33 | phenol-containing compound biosynthetic process (GO:0046189) | 4.93563168 |
| 34 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 4.91555629 |
| 35 | oxygen transport (GO:0015671) | 4.90817966 |
| 36 | dopaminergic neuron differentiation (GO:0071542) | 4.80677932 |
| 37 | suckling behavior (GO:0001967) | 4.78600960 |
| 38 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 4.74873278 |
| 39 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 4.59727611 |
| 40 | vitamin transmembrane transport (GO:0035461) | 4.58019758 |
| 41 | ganglion development (GO:0061548) | 4.57743310 |
| 42 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 4.54639625 |
| 43 | regulation of cardioblast proliferation (GO:0003264) | 4.54639625 |
| 44 | cell migration in hindbrain (GO:0021535) | 4.50485175 |
| 45 | neural crest cell migration (GO:0001755) | 4.45823527 |
| 46 | auditory behavior (GO:0031223) | 4.43150949 |
| 47 | response to amphetamine (GO:0001975) | 4.37303110 |
| 48 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.28681801 |
| 49 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.28681801 |
| 50 | response to nicotine (GO:0035094) | 4.20375381 |
| 51 | proline transport (GO:0015824) | 4.17288449 |
| 52 | regulation of cell maturation (GO:1903429) | 4.05842623 |
| 53 | enteric nervous system development (GO:0048484) | 3.89975200 |
| 54 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.82864608 |
| 55 | skeletal muscle organ development (GO:0060538) | 3.80356502 |
| 56 | adult heart development (GO:0007512) | 3.79316776 |
| 57 | eyelid development in camera-type eye (GO:0061029) | 3.73424221 |
| 58 | regulation of respiratory gaseous exchange (GO:0043576) | 3.72514671 |
| 59 | toxin metabolic process (GO:0009404) | 3.70302433 |
| 60 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.69092421 |
| 61 | parturition (GO:0007567) | 3.67367380 |
| 62 | regulation of vesicle fusion (GO:0031338) | 3.65604559 |
| 63 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.64321792 |
| 64 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.64321792 |
| 65 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.59334183 |
| 66 | neurotransmitter metabolic process (GO:0042133) | 3.59270068 |
| 67 | coronary vasculature morphogenesis (GO:0060977) | 3.57277703 |
| 68 | multi-organism reproductive behavior (GO:0044705) | 3.56722231 |
| 69 | positive regulation of vesicle fusion (GO:0031340) | 3.55816938 |
| 70 | multicellular organismal reproductive behavior (GO:0033057) | 3.55218852 |
| 71 | neural crest cell development (GO:0014032) | 3.49871532 |
| 72 | * response to pain (GO:0048265) | 3.49551172 |
| 73 | regulation of glomerulus development (GO:0090192) | 3.45274614 |
| 74 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.39347964 |
| 75 | detection of temperature stimulus (GO:0016048) | 3.36947341 |
| 76 | neurotransmitter secretion (GO:0007269) | 3.35561840 |
| 77 | nerve growth factor signaling pathway (GO:0038180) | 3.34439838 |
| 78 | apoptotic process involved in development (GO:1902742) | 3.33071571 |
| 79 | reproductive behavior (GO:0019098) | 3.30344962 |
| 80 | innervation (GO:0060384) | 3.28207421 |
| 81 | endocardial cushion morphogenesis (GO:0003203) | 3.27531637 |
| 82 | regulation of neurotransmitter transport (GO:0051588) | 3.24350747 |
| 83 | retinoic acid metabolic process (GO:0042573) | 3.22296335 |
| 84 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.22254866 |
| 85 | adult feeding behavior (GO:0008343) | 3.20484617 |
| 86 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.18161193 |
| 87 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 3.17781726 |
| 88 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 3.17781726 |
| 89 | response to amine (GO:0014075) | 3.17450112 |
| 90 | response to insecticide (GO:0017085) | 3.17431288 |
| 91 | regulation of oxidative phosphorylation (GO:0002082) | 3.16879793 |
| 92 | sequestering of actin monomers (GO:0042989) | 3.15805989 |
| 93 | positive regulation of protein depolymerization (GO:1901881) | 3.15233812 |
| 94 | mating behavior (GO:0007617) | 3.14929061 |
| 95 | regulation of transcription regulatory region DNA binding (GO:2000677) | 3.14609082 |
| 96 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.11122290 |
| 97 | dopamine transport (GO:0015872) | 3.09740835 |
| 98 | mechanosensory behavior (GO:0007638) | 3.09724669 |
| 99 | outflow tract septum morphogenesis (GO:0003148) | 3.09005451 |
| 100 | embryonic epithelial tube formation (GO:0001838) | 3.08810273 |
| 101 | primary amino compound metabolic process (GO:1901160) | 3.06717491 |
| 102 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.06184988 |
| 103 | regulation of neurotransmitter secretion (GO:0046928) | 3.05487723 |
| 104 | positive regulation of catecholamine secretion (GO:0033605) | 3.04994532 |
| 105 | cellular copper ion homeostasis (GO:0006878) | 3.03964828 |
| 106 | negative regulation of macrophage differentiation (GO:0045650) | 3.01699870 |
| 107 | apoptotic process involved in morphogenesis (GO:0060561) | 3.00256381 |
| 108 | nucleobase catabolic process (GO:0046113) | 3.00243435 |
| 109 | phenol-containing compound catabolic process (GO:0019336) | 20.7835295 |
| 110 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.99199391 |
| 111 | positive regulation of neurotransmitter transport (GO:0051590) | 2.96769716 |
| 112 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.93631925 |
| 113 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 2.92804937 |
| 114 | fear response (GO:0042596) | 2.89330082 |
| 115 | epithelial tube formation (GO:0072175) | 2.89200582 |
| 116 | phenol-containing compound metabolic process (GO:0018958) | 2.86318503 |
| 117 | regulation of neurotransmitter uptake (GO:0051580) | 2.83965877 |
| 118 | ear development (GO:0043583) | 2.83603889 |
| 119 | tyrosine metabolic process (GO:0006570) | 2.82112308 |
| 120 | gas transport (GO:0015669) | 2.81021549 |
| 121 | estrogen biosynthetic process (GO:0006703) | 2.80434750 |
| 122 | mesenchymal cell development (GO:0014031) | 2.78815914 |
| 123 | cardiac chamber formation (GO:0003207) | 2.78480027 |
| 124 | mesenchyme morphogenesis (GO:0072132) | 2.77805265 |
| 125 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.77533848 |
| 126 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.74895814 |
| 127 | alanine transport (GO:0032328) | 2.74626256 |
| 128 | temperature homeostasis (GO:0001659) | 2.74551391 |
| 129 | negative regulation of cell cycle arrest (GO:0071157) | 2.73646528 |
| 130 | phospholipid scrambling (GO:0017121) | 2.71667585 |
| 131 | negative regulation of dendrite development (GO:2000171) | 2.71216285 |
| 132 | positive regulation of metanephros development (GO:0072216) | 2.69445824 |
| 133 | neuron maturation (GO:0042551) | 2.68498808 |
| 134 | glycine transport (GO:0015816) | 2.67615522 |
| 135 | blood vessel remodeling (GO:0001974) | 2.67461859 |
| 136 | regulation of neurotransmitter levels (GO:0001505) | 2.66060956 |
| 137 | head development (GO:0060322) | 2.65875255 |
| 138 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.65804450 |
| 139 | lung epithelium development (GO:0060428) | 2.65181533 |
| 140 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 2.63737040 |
| 141 | embryonic digit morphogenesis (GO:0042733) | 2.62840071 |
| 142 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.61510677 |
| 143 | axon extension involved in axon guidance (GO:0048846) | 2.61510677 |
| 144 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.60965341 |
| 145 | positive regulation of vasoconstriction (GO:0045907) | 2.60395640 |
| 146 | cell differentiation in hindbrain (GO:0021533) | 2.59974294 |
| 147 | regulation of microtubule polymerization (GO:0031113) | 2.59049678 |
| 148 | serotonin metabolic process (GO:0042428) | 2.58289831 |
| 149 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.55882534 |
| 150 | lung vasculature development (GO:0060426) | 2.55791202 |
| 151 | * catecholamine transport (GO:0051937) | 2.55247728 |
| 152 | spinal cord motor neuron differentiation (GO:0021522) | 2.54155855 |
| 153 | diaphragm development (GO:0060539) | 2.53583247 |
| 154 | cell differentiation in spinal cord (GO:0021515) | 2.51372621 |
| 155 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.51146309 |
| 156 | negative regulation of astrocyte differentiation (GO:0048712) | 2.50502990 |
| 157 | behavioral response to nicotine (GO:0035095) | 13.8431362 |
| 158 | sympathetic nervous system development (GO:0048485) | 11.1418395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 9.13114457 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.66017168 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.35929110 |
| 4 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 3.81721267 |
| 5 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.16266301 |
| 6 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 3.02892330 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.86340018 |
| 8 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.74922499 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.69451118 |
| 10 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.50405827 |
| 11 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.36397322 |
| 12 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.33198288 |
| 13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.27527520 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.25987683 |
| 15 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.25835558 |
| 16 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.24281177 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.23162161 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.22781611 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.22781611 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.21652752 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.21281315 |
| 22 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.18671361 |
| 23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.18156463 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.09542935 |
| 25 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.08851074 |
| 26 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.07143115 |
| 27 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.05506525 |
| 28 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.02438287 |
| 29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.01009673 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.00982242 |
| 31 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.98871711 |
| 32 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.96567482 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.96513766 |
| 34 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.94405916 |
| 35 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.89588036 |
| 36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.83863521 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.80747196 |
| 38 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.79451286 |
| 39 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.78305306 |
| 40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.74535771 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74007558 |
| 42 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.73663993 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.71051860 |
| 44 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.70391349 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69094300 |
| 46 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.64867342 |
| 47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.61917078 |
| 48 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.59844322 |
| 49 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.57001828 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56836929 |
| 51 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.55417273 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.54575802 |
| 53 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.51092467 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49437014 |
| 55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.45013898 |
| 56 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.43347444 |
| 57 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.41075701 |
| 58 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39241867 |
| 59 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37469134 |
| 60 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.36985543 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36468057 |
| 62 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.35294941 |
| 63 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.33084171 |
| 64 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33064067 |
| 65 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.31547560 |
| 66 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.31138693 |
| 67 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30830159 |
| 68 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.30743523 |
| 69 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.30225530 |
| 70 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.30218123 |
| 71 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.28181723 |
| 72 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.28041387 |
| 73 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24756931 |
| 74 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.24574859 |
| 75 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.23710722 |
| 76 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.22922919 |
| 77 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21743174 |
| 78 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.21415597 |
| 79 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.18527234 |
| 80 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.18204347 |
| 81 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.18142958 |
| 82 | FUS_26573619_Chip-Seq_HEK293_Human | 1.17414009 |
| 83 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16968946 |
| 84 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.16189864 |
| 85 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.15563772 |
| 86 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.14695441 |
| 87 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14304429 |
| 88 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.12726951 |
| 89 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.12670143 |
| 90 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12269747 |
| 91 | JUN_21703547_ChIP-Seq_K562_Human | 1.10292470 |
| 92 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10159863 |
| 93 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.07990646 |
| 94 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07114727 |
| 95 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.07056382 |
| 96 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06796501 |
| 97 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.04686364 |
| 98 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03201033 |
| 99 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03171956 |
| 100 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.03072433 |
| 101 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02942699 |
| 102 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.01535736 |
| 103 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01300019 |
| 104 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.00675706 |
| 105 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.99371195 |
| 106 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98664176 |
| 107 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98664176 |
| 108 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97042140 |
| 109 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.96178790 |
| 110 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.95357969 |
| 111 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.94949984 |
| 112 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.94805907 |
| 113 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.94756972 |
| 114 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.93843807 |
| 115 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92518178 |
| 116 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.92320195 |
| 117 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.92060340 |
| 118 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90503393 |
| 119 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.89917870 |
| 120 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.88685929 |
| 121 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.88676817 |
| 122 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88226427 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88098396 |
| 124 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88098396 |
| 125 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.87015068 |
| 126 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86778709 |
| 127 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.86124076 |
| 128 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86020108 |
| 129 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.85474442 |
| 130 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85096963 |
| 131 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84495359 |
| 132 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.84460668 |
| 133 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84296025 |
| 134 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.84261447 |
| 135 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84225976 |
| 136 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84046896 |
| 137 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.84009969 |
| 138 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.83662501 |
| 139 | PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.83239321 |
| 140 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.83091542 |
| 141 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.82792287 |
| 142 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.82723220 |
| 143 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.81998698 |
| 144 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.81997965 |
| 145 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.81851440 |
| 146 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.81817162 |
| 147 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.81053637 |
| 148 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.80412378 |
| 149 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.80328106 |
| 150 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80261999 |
| 151 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79564538 |
| 152 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.79329303 |
| 153 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.78768004 |
| 154 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.78747438 |
| 155 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.78747438 |
| 156 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.77863081 |
| 157 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.77772946 |
| 158 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.77552910 |
| 159 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.77038096 |
| 160 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.76395178 |
| 161 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.76327976 |
| 162 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.75927006 |
| 163 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.75903212 |
| 164 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.73788081 |
| 165 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.73653438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010386_abnormal_urinary_bladder | 6.54220401 |
| 2 | MP0002638_abnormal_pupillary_reflex | 5.64266497 |
| 3 | MP0001905_abnormal_dopamine_level | 3.69362719 |
| 4 | MP0002009_preneoplasia | 3.29610532 |
| 5 | MP0000538_abnormal_urinary_bladder | 3.28760507 |
| 6 | MP0004270_analgesia | 2.82959211 |
| 7 | MP0006276_abnormal_autonomic_nervous | 2.67351995 |
| 8 | MP0000372_irregular_coat_pigmentation | 2.67325677 |
| 9 | MP0001529_abnormal_vocalization | 2.62225638 |
| 10 | MP0001440_abnormal_grooming_behavior | 2.58769335 |
| 11 | MP0002751_abnormal_autonomic_nervous | 2.58403268 |
| 12 | MP0004858_abnormal_nervous_system | 2.36451934 |
| 13 | MP0003868_abnormal_feces_composition | 2.29404362 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.28823120 |
| 15 | MP0002822_catalepsy | 13.0677570 |
| 16 | MP0004264_abnormal_extraembryonic_tissu | 1.97035184 |
| 17 | MP0005386_behavior/neurological_phenoty | 1.82247272 |
| 18 | MP0004924_abnormal_behavior | 1.82247272 |
| 19 | MP0009379_abnormal_foot_pigmentation | 1.82129500 |
| 20 | * MP0009745_abnormal_behavioral_response | 1.72486254 |
| 21 | MP0001501_abnormal_sleep_pattern | 1.67649393 |
| 22 | MP0005197_abnormal_uvea_morphology | 1.64281437 |
| 23 | MP0003279_aneurysm | 1.60536431 |
| 24 | * MP0001970_abnormal_pain_threshold | 1.58932136 |
| 25 | MP0005408_hypopigmentation | 1.56588692 |
| 26 | MP0002127_abnormal_cardiovascular_syste | 1.54464017 |
| 27 | MP0001756_abnormal_urination | 1.32207155 |
| 28 | MP0002163_abnormal_gland_morphology | 1.30602134 |
| 29 | MP0002064_seizures | 1.29512659 |
| 30 | MP0004272_abnormal_basement_membrane | 1.22929752 |
| 31 | * MP0002733_abnormal_thermal_nociception | 1.19827664 |
| 32 | MP0001664_abnormal_digestion | 1.18606378 |
| 33 | * MP0003635_abnormal_synaptic_transmissio | 1.17306672 |
| 34 | MP0004859_abnormal_synaptic_plasticity | 1.14698448 |
| 35 | * MP0002572_abnormal_emotion/affect_behav | 1.11271603 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.07460139 |
| 37 | MP0008569_lethality_at_weaning | 1.07155381 |
| 38 | MP0002063_abnormal_learning/memory/cond | 0.99916964 |
| 39 | MP0002272_abnormal_nervous_system | 0.98145842 |
| 40 | MP0005085_abnormal_gallbladder_physiolo | 0.97998069 |
| 41 | MP0002160_abnormal_reproductive_system | 0.95039699 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 0.94682962 |
| 43 | MP0002184_abnormal_innervation | 0.93674447 |
| 44 | MP0005646_abnormal_pituitary_gland | 0.87597702 |
| 45 | MP0005171_absent_coat_pigmentation | 0.86758298 |
| 46 | MP0005360_urolithiasis | 0.86749277 |
| 47 | MP0000516_abnormal_urinary_system | 0.86396936 |
| 48 | MP0005367_renal/urinary_system_phenotyp | 0.86396936 |
| 49 | MP0005409_darkened_coat_color | 0.86015810 |
| 50 | MP0008874_decreased_physiological_sensi | 0.83225216 |
| 51 | MP0003638_abnormal_response/metabolism_ | 0.83181890 |
| 52 | * MP0008872_abnormal_physiological_respon | 0.81622403 |
| 53 | MP0003122_maternal_imprinting | 0.79975443 |
| 54 | MP0003937_abnormal_limbs/digits/tail_de | 0.79280923 |
| 55 | MP0002735_abnormal_chemical_nociception | 0.75922166 |
| 56 | * MP0003633_abnormal_nervous_system | 0.75669296 |
| 57 | * MP0003631_nervous_system_phenotype | 0.74783414 |
| 58 | MP0001188_hyperpigmentation | 0.73976222 |
| 59 | MP0001340_abnormal_eyelid_morphology | 0.73921236 |
| 60 | MP0005379_endocrine/exocrine_gland_phen | 0.73861550 |
| 61 | MP0005365_abnormal_bile_salt | 0.71880611 |
| 62 | MP0000013_abnormal_adipose_tissue | 0.71152707 |
| 63 | MP0002909_abnormal_adrenal_gland | 0.71139912 |
| 64 | MP0003115_abnormal_respiratory_system | 0.70176321 |
| 65 | MP0009697_abnormal_copulation | 0.69888085 |
| 66 | MP0002166_altered_tumor_susceptibility | 0.68029480 |
| 67 | MP0000778_abnormal_nervous_system | 0.67144121 |
| 68 | MP0000955_abnormal_spinal_cord | 0.66767164 |
| 69 | MP0000751_myopathy | 0.66317296 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 0.66146934 |
| 71 | MP0003942_abnormal_urinary_system | 0.65923433 |
| 72 | MP0001270_distended_abdomen | 0.64511810 |
| 73 | MP0005670_abnormal_white_adipose | 0.64463829 |
| 74 | MP0004085_abnormal_heartbeat | 0.64331300 |
| 75 | MP0004883_abnormal_blood_vessel | 0.63593258 |
| 76 | MP0010094_abnormal_chromosome_stability | 0.62323247 |
| 77 | MP0004811_abnormal_neuron_physiology | 0.61736496 |
| 78 | MP0008438_abnormal_cutaneous_collagen | 0.61350238 |
| 79 | MP0005187_abnormal_penis_morphology | 0.61198576 |
| 80 | MP0002067_abnormal_sensory_capabilities | 0.60891273 |
| 81 | MP0000681_abnormal_thyroid_gland | 0.59749461 |
| 82 | MP0005275_abnormal_skin_tensile | 0.58798543 |
| 83 | MP0005394_taste/olfaction_phenotype | 0.58336859 |
| 84 | MP0005499_abnormal_olfactory_system | 0.58336859 |
| 85 | MP0002090_abnormal_vision | 0.58146396 |
| 86 | MP0003632_abnormal_nervous_system | 0.57482577 |
| 87 | MP0003567_abnormal_fetal_cardiomyocyte | 0.57360605 |
| 88 | MP0002557_abnormal_social/conspecific_i | 0.56579258 |
| 89 | MP0005083_abnormal_biliary_tract | 0.56285206 |
| 90 | MP0003077_abnormal_cell_cycle | 0.55690048 |
| 91 | MP0008789_abnormal_olfactory_epithelium | 0.54033762 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.53372774 |
| 93 | MP0008057_abnormal_DNA_replication | 0.53184608 |
| 94 | MP0010368_abnormal_lymphatic_system | 0.51467216 |
| 95 | MP0002882_abnormal_neuron_morphology | 0.51028328 |
| 96 | MP0001666_abnormal_nutrient_absorption | 0.50948401 |
| 97 | MP0008260_abnormal_autophagy | 0.50739923 |
| 98 | MP0000749_muscle_degeneration | 0.50298320 |
| 99 | MP0005503_abnormal_tendon_morphology | 0.49270744 |
| 100 | MP0000613_abnormal_salivary_gland | 0.48431040 |
| 101 | MP0005623_abnormal_meninges_morphology | 0.47602776 |
| 102 | MP0006138_congestive_heart_failure | 0.47583430 |
| 103 | * MP0002066_abnormal_motor_capabilities/c | 0.46960446 |
| 104 | MP0001968_abnormal_touch/_nociception | 0.46683441 |
| 105 | MP0002069_abnormal_eating/drinking_beha | 0.46572928 |
| 106 | MP0002697_abnormal_eye_size | 0.45279558 |
| 107 | MP0001730_embryonic_growth_arrest | 0.45165197 |
| 108 | MP0000747_muscle_weakness | 0.45108436 |
| 109 | MP0000639_abnormal_adrenal_gland | 0.45069600 |
| 110 | MP0000049_abnormal_middle_ear | 0.44900537 |
| 111 | * MP0003953_abnormal_hormone_level | 0.42856241 |
| 112 | MP0003698_abnormal_male_reproductive | 0.41846062 |
| 113 | MP0002138_abnormal_hepatobiliary_system | 0.40644840 |
| 114 | MP0005193_abnormal_anterior_eye | 0.40625732 |
| 115 | MP0001731_abnormal_postnatal_growth | 0.40621358 |
| 116 | MP0003329_amyloid_beta_deposits | 0.40429535 |
| 117 | MP0002109_abnormal_limb_morphology | 0.40160133 |
| 118 | MP0005410_abnormal_fertilization | 0.38997483 |
| 119 | MP0002752_abnormal_somatic_nervous | 0.38943685 |
| 120 | MP0000249_abnormal_blood_vessel | 0.38890957 |
| 121 | MP0008932_abnormal_embryonic_tissue | 0.38331983 |
| 122 | MP0002152_abnormal_brain_morphology | 0.38302904 |
| 123 | MP0002082_postnatal_lethality | 0.37783768 |
| 124 | MP0000767_abnormal_smooth_muscle | 0.37046778 |
| 125 | MP0000534_abnormal_ureter_morphology | 0.36596463 |
| 126 | MP0008058_abnormal_DNA_repair | 0.36223036 |
| 127 | MP0002006_tumorigenesis | 0.36191282 |
| 128 | MP0002106_abnormal_muscle_physiology | 0.35608282 |
| 129 | MP0002332_abnormal_exercise_endurance | 0.35514076 |
| 130 | MP0009046_muscle_twitch | 0.35426701 |
| 131 | MP0000428_abnormal_craniofacial_morphol | 0.34942247 |
| 132 | MP0010769_abnormal_survival | 0.34435223 |
| 133 | MP0002084_abnormal_developmental_patter | 0.33510016 |
| 134 | MP0010768_mortality/aging | 0.33307444 |
| 135 | MP0001348_abnormal_lacrimal_gland | 0.33241753 |
| 136 | MP0010770_preweaning_lethality | 0.32861921 |
| 137 | MP0009053_abnormal_anal_canal | 0.32669903 |
| 138 | MP0001661_extended_life_span | 0.32392220 |
| 139 | MP0000477_abnormal_intestine_morphology | 0.32096575 |
| 140 | MP0002269_muscular_atrophy | 0.31739123 |
| 141 | MP0005369_muscle_phenotype | 0.31482565 |
| 142 | MP0008875_abnormal_xenobiotic_pharmacok | 0.31296537 |
| 143 | MP0003111_abnormal_nucleus_morphology | 0.30743343 |
| 144 | MP0008770_decreased_survivor_rate | 0.29962014 |
| 145 | MP0002139_abnormal_hepatobiliary_system | 0.28918386 |
| 146 | MP0000762_abnormal_tongue_morphology | 0.28882680 |
| 147 | MP0003195_calcinosis | 0.28717225 |
| 148 | MP0005647_abnormal_sex_gland | 0.28370997 |
| 149 | MP0001544_abnormal_cardiovascular_syste | 0.28082330 |
| 150 | MP0005385_cardiovascular_system_phenoty | 0.28082330 |
| 151 | MP0001764_abnormal_homeostasis | 0.27879257 |
| 152 | MP0001929_abnormal_gametogenesis | 0.27402206 |
| 153 | MP0003866_abnormal_defecation | 0.26056385 |
| 154 | MP0000647_abnormal_sebaceous_gland | 0.25216711 |
| 155 | MP0003935_abnormal_craniofacial_develop | 0.24952136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.51293175 |
| 2 | * Abnormal autonomic nervous system physiology (HP:0012332) | 6.34207067 |
| 3 | Annular pancreas (HP:0001734) | 5.96150508 |
| 4 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 5.50688063 |
| 5 | Hypotension (HP:0002615) | 5.37130173 |
| 6 | Amblyopia (HP:0000646) | 5.17806213 |
| 7 | Limb dystonia (HP:0002451) | 5.09247243 |
| 8 | Exotropia (HP:0000577) | 4.82947354 |
| 9 | Failure to thrive in infancy (HP:0001531) | 4.59204257 |
| 10 | Impulsivity (HP:0100710) | 4.57540352 |
| 11 | Bicornuate uterus (HP:0000813) | 4.56119775 |
| 12 | Abnormality of the parathyroid morphology (HP:0011766) | 4.54934405 |
| 13 | Intestinal atresia (HP:0011100) | 4.50629537 |
| 14 | Autoamputation (HP:0001218) | 4.50492463 |
| 15 | Esophageal atresia (HP:0002032) | 4.46789240 |
| 16 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 4.06015035 |
| 17 | Depressed nasal tip (HP:0000437) | 4.04125306 |
| 18 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 3.94375831 |
| 19 | Arthropathy (HP:0003040) | 3.72883366 |
| 20 | Supernumerary spleens (HP:0009799) | 3.59695020 |
| 21 | Myotonia (HP:0002486) | 3.59056030 |
| 22 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 3.53651702 |
| 23 | Bilateral microphthalmos (HP:0007633) | 3.49750800 |
| 24 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.47182408 |
| 25 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 3.39254073 |
| 26 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.34700836 |
| 27 | Abnormality of the 2nd finger (HP:0004100) | 3.31111930 |
| 28 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 3.08284945 |
| 29 | Hypoventilation (HP:0002791) | 3.00885312 |
| 30 | Abnormality of pain sensation (HP:0010832) | 3.00357989 |
| 31 | Impaired pain sensation (HP:0007328) | 3.00357989 |
| 32 | Asymmetry of the thorax (HP:0001555) | 2.91997997 |
| 33 | Recurrent corneal erosions (HP:0000495) | 2.89473862 |
| 34 | Hyperthyroidism (HP:0000836) | 2.85839903 |
| 35 | External ophthalmoplegia (HP:0000544) | 2.84765228 |
| 36 | Abnormal pancreas size (HP:0012094) | 2.83468680 |
| 37 | Hypoplasia of the uterus (HP:0000013) | 2.81473699 |
| 38 | Dysautonomia (HP:0002459) | 2.76446146 |
| 39 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.74797085 |
| 40 | Bowel diverticulosis (HP:0005222) | 2.73849468 |
| 41 | Abnormality of the aortic arch (HP:0012303) | 2.72450439 |
| 42 | Gastrointestinal atresia (HP:0002589) | 2.70121651 |
| 43 | Abnormal pupillary function (HP:0007686) | 2.69352002 |
| 44 | Renal dysplasia (HP:0000110) | 2.65345618 |
| 45 | Thyroid carcinoma (HP:0002890) | 2.53869157 |
| 46 | Anhidrosis (HP:0000970) | 2.45216910 |
| 47 | Ectopic kidney (HP:0000086) | 2.43710355 |
| 48 | Action tremor (HP:0002345) | 2.42230505 |
| 49 | Sensory axonal neuropathy (HP:0003390) | 2.38657996 |
| 50 | Episodic fever (HP:0001954) | 2.37778883 |
| 51 | Progressive cerebellar ataxia (HP:0002073) | 2.36859647 |
| 52 | Aplastic anemia (HP:0001915) | 2.34544253 |
| 53 | Atonic seizures (HP:0010819) | 2.32677833 |
| 54 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.31656451 |
| 55 | Glossoptosis (HP:0000162) | 2.30444843 |
| 56 | Agitation (HP:0000713) | 2.30277233 |
| 57 | Abnormality of the vocal cords (HP:0008777) | 2.29747151 |
| 58 | Neuroectodermal neoplasm (HP:0030061) | 2.29740088 |
| 59 | Neuroepithelial neoplasm (HP:0030063) | 2.29740088 |
| 60 | Nervous tissue neoplasm (HP:0030060) | 2.29740088 |
| 61 | Focal motor seizures (HP:0011153) | 2.28120206 |
| 62 | Focal seizures (HP:0007359) | 2.24403893 |
| 63 | Asplenia (HP:0001746) | 2.22288933 |
| 64 | Malignant neoplasm of the central nervous system (HP:0100836) | 2.18746580 |
| 65 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.18193989 |
| 66 | Postural tremor (HP:0002174) | 2.18057998 |
| 67 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.16949783 |
| 68 | Papilledema (HP:0001085) | 2.16836382 |
| 69 | Pheochromocytoma (HP:0002666) | 2.15374410 |
| 70 | Neonatal onset (HP:0003623) | 2.14919609 |
| 71 | Disproportionate tall stature (HP:0001519) | 2.14877559 |
| 72 | Truncus arteriosus (HP:0001660) | 2.13860403 |
| 73 | Occipital encephalocele (HP:0002085) | 2.13157158 |
| 74 | Hyperparathyroidism (HP:0000843) | 2.11530222 |
| 75 | Wrist flexion contracture (HP:0001239) | 2.11484108 |
| 76 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.10671319 |
| 77 | Bradycardia (HP:0001662) | 2.10372027 |
| 78 | Limb hypertonia (HP:0002509) | 2.08631536 |
| 79 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.04921139 |
| 80 | Metaphyseal dysplasia (HP:0100255) | 2.00374210 |
| 81 | Abnormality of dental color (HP:0011073) | 2.00289682 |
| 82 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.00138791 |
| 83 | Hypothermia (HP:0002045) | 18.5977741 |
| 84 | Orthostatic hypotension (HP:0001278) | 11.8442424 |
| 85 | Neonatal hypoglycemia (HP:0001998) | 10.7632058 |
| 86 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.99694873 |
| 87 | Vaginal atresia (HP:0000148) | 1.98096799 |
| 88 | Neuroblastic tumors (HP:0004376) | 1.96152909 |
| 89 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.96152909 |
| 90 | Neuroblastoma (HP:0003006) | 1.96152909 |
| 91 | Primitive neuroectodermal tumor (HP:0030065) | 1.96152909 |
| 92 | Genital tract atresia (HP:0001827) | 1.94827034 |
| 93 | Neuroendocrine neoplasm (HP:0100634) | 1.93567594 |
| 94 | Hypotrichosis (HP:0001006) | 1.92537228 |
| 95 | Generalized tonic-clonic seizures (HP:0002069) | 1.89773384 |
| 96 | Abnormality of the duodenum (HP:0002246) | 1.88469952 |
| 97 | Febrile seizures (HP:0002373) | 1.85289037 |
| 98 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.83854588 |
| 99 | Deep venous thrombosis (HP:0002625) | 1.82327025 |
| 100 | Attenuation of retinal blood vessels (HP:0007843) | 1.82074324 |
| 101 | Acute necrotizing encephalopathy (HP:0006965) | 1.81394613 |
| 102 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.80600478 |
| 103 | Abnormality of the corticospinal tract (HP:0002492) | 1.79663185 |
| 104 | Redundant skin (HP:0001582) | 1.78814640 |
| 105 | Ulnar claw (HP:0001178) | 1.78405384 |
| 106 | Insidious onset (HP:0003587) | 1.74950299 |
| 107 | Termporal pattern (HP:0011008) | 1.74950299 |
| 108 | Shawl scrotum (HP:0000049) | 1.73153097 |
| 109 | Adducted thumb (HP:0001181) | 1.71048126 |
| 110 | Increased hepatocellular lipid droplets (HP:0006565) | 1.70309155 |
| 111 | Emotional lability (HP:0000712) | 1.69551599 |
| 112 | Spontaneous hematomas (HP:0007420) | 1.68561736 |
| 113 | Anxiety (HP:0000739) | 1.68255176 |
| 114 | Visual hallucinations (HP:0002367) | 1.67876478 |
| 115 | Goiter (HP:0000853) | 1.67624151 |
| 116 | Hyporeflexia of lower limbs (HP:0002600) | 1.67525877 |
| 117 | Progressive macrocephaly (HP:0004481) | 1.65903983 |
| 118 | Pulmonary hypoplasia (HP:0002089) | 1.65463065 |
| 119 | Axonal loss (HP:0003447) | 1.62558703 |
| 120 | Menstrual irregularities (HP:0000858) | 1.62449863 |
| 121 | Growth hormone excess (HP:0000845) | 1.61816750 |
| 122 | Non-midline cleft lip (HP:0100335) | 1.61514981 |
| 123 | Short palpebral fissure (HP:0012745) | 1.60830610 |
| 124 | Neoplasm of the thyroid gland (HP:0100031) | 1.59509319 |
| 125 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.58019963 |
| 126 | Absence seizures (HP:0002121) | 1.57988551 |
| 127 | Short clavicles (HP:0000894) | 1.57079336 |
| 128 | Renal agenesis (HP:0000104) | 1.56691349 |
| 129 | Mitochondrial inheritance (HP:0001427) | 1.56679248 |
| 130 | Xerostomia (HP:0000217) | 1.55963781 |
| 131 | Renal Fanconi syndrome (HP:0001994) | 1.54783601 |
| 132 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.54603454 |
| 133 | Intellectual disability, mild (HP:0001256) | 1.54064656 |
| 134 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.52470885 |
| 135 | Hypoplasia of the brainstem (HP:0002365) | 1.52246167 |
| 136 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.52246167 |
| 137 | Stenosis of the external auditory canal (HP:0000402) | 1.51915476 |
| 138 | Palpitations (HP:0001962) | 1.51734076 |
| 139 | Craniofacial dystonia (HP:0012179) | 1.50216870 |
| 140 | Coarctation of aorta (HP:0001680) | 1.49357681 |
| 141 | Wormian bones (HP:0002645) | 1.48395893 |
| 142 | Abnormality of the parietal bone (HP:0002696) | 1.48204181 |
| 143 | Facial shape deformation (HP:0011334) | 1.48165632 |
| 144 | Potter facies (HP:0002009) | 1.48165632 |
| 145 | Venous insufficiency (HP:0005293) | 1.47476745 |
| 146 | Lipid accumulation in hepatocytes (HP:0006561) | 1.47428346 |
| 147 | Cerebral hemorrhage (HP:0001342) | 1.46804457 |
| 148 | Ankle clonus (HP:0011448) | 1.45937845 |
| 149 | Hypercortisolism (HP:0001578) | 1.45655135 |
| 150 | Intestinal polyposis (HP:0200008) | 1.45503503 |
| 151 | Rapidly progressive (HP:0003678) | 1.43502887 |
| 152 | Abnormality of the femoral head (HP:0003368) | 1.42467333 |
| 153 | Hypercalcemia (HP:0003072) | 1.41998836 |
| 154 | Intestinal polyp (HP:0005266) | 1.41776984 |
| 155 | Torticollis (HP:0000473) | 1.40896226 |
| 156 | Retinal atrophy (HP:0001105) | 1.39991514 |
| 157 | Overfolded helix (HP:0000396) | 1.38158313 |
| 158 | Asymmetric septal hypertrophy (HP:0001670) | 1.37820781 |
| 159 | Vertebral arch anomaly (HP:0008438) | 1.35924457 |
| 160 | Focal dystonia (HP:0004373) | 1.35693771 |
| 161 | Self-mutilation (HP:0000742) | 1.35662476 |
| 162 | Hyperhidrosis (HP:0000975) | 1.35248282 |
| 163 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.34653428 |
| 164 | Abnormality of femoral epiphyses (HP:0006499) | 1.34653428 |
| 165 | Prolonged partial thromboplastin time (HP:0003645) | 1.33884978 |
| 166 | Abnormal lung lobation (HP:0002101) | 1.33478526 |
| 167 | Breast hypoplasia (HP:0003187) | 1.31912876 |
| 168 | Oligohydramnios (HP:0001562) | 1.31851763 |
| 169 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.31059397 |
| 170 | Intrahepatic cholestasis (HP:0001406) | 1.30563102 |
| 171 | Anophthalmia (HP:0000528) | 1.30507993 |
| 172 | 2-3 toe syndactyly (HP:0004691) | 1.29557104 |
| 173 | Abnormality of secondary sexual hair (HP:0009888) | 1.24926963 |
| 174 | Abnormality of the axillary hair (HP:0100134) | 1.24926963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK1 | 7.71408018 |
| 2 | GRK7 | 6.94077188 |
| 3 | MATK | 4.63751598 |
| 4 | GRK5 | 3.80079062 |
| 5 | ZAK | 3.01690434 |
| 6 | MAPKAPK5 | 2.46866438 |
| 7 | EIF2AK1 | 2.43855822 |
| 8 | TLK1 | 2.36423317 |
| 9 | DDR2 | 2.30505421 |
| 10 | MAP3K4 | 2.19971715 |
| 11 | CSNK1G3 | 2.05698859 |
| 12 | SCYL2 | 2.03156601 |
| 13 | MAP2K1 | 2.02258018 |
| 14 | ADRBK1 | 2.00323349 |
| 15 | EIF2AK3 | 1.96843028 |
| 16 | NTRK3 | 1.93861665 |
| 17 | TIE1 | 1.87777437 |
| 18 | PNCK | 1.84020761 |
| 19 | MAP3K12 | 1.73293561 |
| 20 | VRK2 | 1.71847820 |
| 21 | SRPK1 | 1.71697565 |
| 22 | CSNK1G2 | 1.67816504 |
| 23 | MAP2K7 | 1.66893335 |
| 24 | MAP3K2 | 1.59406508 |
| 25 | ICK | 1.55225697 |
| 26 | TSSK6 | 1.47947306 |
| 27 | NME2 | 1.47800539 |
| 28 | GRK6 | 1.45363897 |
| 29 | EEF2K | 1.39667606 |
| 30 | CSNK1G1 | 1.38347811 |
| 31 | LIMK1 | 1.37619609 |
| 32 | ARAF | 1.30403583 |
| 33 | BUB1 | 1.29521463 |
| 34 | MINK1 | 1.25127556 |
| 35 | DAPK2 | 1.20006735 |
| 36 | DYRK1B | 1.19562419 |
| 37 | MAP2K4 | 1.19232797 |
| 38 | TESK1 | 1.19057116 |
| 39 | PTK2B | 1.12558485 |
| 40 | VRK1 | 1.11031410 |
| 41 | MAP3K10 | 1.10973958 |
| 42 | UHMK1 | 1.08925459 |
| 43 | TAF1 | 1.06273609 |
| 44 | INSRR | 1.06205125 |
| 45 | NTRK2 | 0.99782370 |
| 46 | SMG1 | 0.98139625 |
| 47 | ERBB2 | 0.96884791 |
| 48 | ATR | 0.95970968 |
| 49 | FRK | 0.92569757 |
| 50 | CAMKK2 | 0.92345365 |
| 51 | MYLK | 0.92086511 |
| 52 | WNK1 | 0.91199506 |
| 53 | NME1 | 0.89073930 |
| 54 | KSR2 | 0.88288991 |
| 55 | MARK1 | 0.87561660 |
| 56 | MAPK4 | 0.86350496 |
| 57 | TRPM7 | 0.83612852 |
| 58 | SIK3 | 0.83057860 |
| 59 | PLK4 | 0.80210282 |
| 60 | RPS6KA2 | 0.76014970 |
| 61 | TTK | 0.75055915 |
| 62 | MAP4K2 | 0.75044921 |
| 63 | CDC7 | 0.73117900 |
| 64 | NEK1 | 0.72521204 |
| 65 | CHEK2 | 0.72280176 |
| 66 | SGK494 | 0.68161088 |
| 67 | SGK223 | 0.68161088 |
| 68 | CAMK2B | 0.67529543 |
| 69 | AKT3 | 0.66488918 |
| 70 | MTOR | 0.66190500 |
| 71 | LATS2 | 0.64823031 |
| 72 | DAPK1 | 0.64551113 |
| 73 | CDK7 | 0.63935185 |
| 74 | FGFR2 | 0.63471099 |
| 75 | EPHB2 | 0.61839564 |
| 76 | PLK2 | 0.60839753 |
| 77 | CSNK1A1L | 0.57764079 |
| 78 | MUSK | 0.57238746 |
| 79 | CAMK2G | 0.57169724 |
| 80 | PHKG1 | 0.56934307 |
| 81 | PHKG2 | 0.56934307 |
| 82 | MAP2K2 | 0.55947437 |
| 83 | CDK3 | 0.55746709 |
| 84 | LMTK2 | 0.54861372 |
| 85 | DYRK2 | 0.52520945 |
| 86 | PIM2 | 0.51568144 |
| 87 | CDK5 | 0.50557869 |
| 88 | CAMK2D | 0.49418286 |
| 89 | FGR | 0.48191206 |
| 90 | MELK | 0.47677094 |
| 91 | MAPK11 | 0.46388266 |
| 92 | CAMK4 | 0.45911468 |
| 93 | CASK | 0.45423388 |
| 94 | ATM | 0.43641200 |
| 95 | AKT1 | 0.43556966 |
| 96 | AURKA | 0.43341979 |
| 97 | TYRO3 | 0.43305277 |
| 98 | MKNK2 | 0.42682384 |
| 99 | CDK18 | 0.42491435 |
| 100 | PRKCG | 0.42471283 |
| 101 | STK24 | 0.42180261 |
| 102 | ALK | 0.42092325 |
| 103 | CDK15 | 0.41874580 |
| 104 | PLK1 | 0.41666626 |
| 105 | RPS6KA5 | 0.41616253 |
| 106 | ADRBK2 | 0.41353906 |
| 107 | PDGFRB | 0.41063724 |
| 108 | MAPK13 | 0.41032750 |
| 109 | WNK4 | 0.40575730 |
| 110 | CDK2 | 0.39548040 |
| 111 | BMPR1B | 0.39520605 |
| 112 | EPHA3 | 0.38797114 |
| 113 | STK39 | 0.38543707 |
| 114 | PLK3 | 0.38428986 |
| 115 | DYRK3 | 0.38379245 |
| 116 | IGF1R | 0.38250786 |
| 117 | LRRK2 | 0.37843796 |
| 118 | CDK14 | 0.37602183 |
| 119 | CSNK2A2 | 0.37207890 |
| 120 | PTK2 | 0.37098646 |
| 121 | MAP3K11 | 0.36884970 |
| 122 | PRKACA | 0.36318381 |
| 123 | CDK11A | 0.35618310 |
| 124 | CSNK1E | 0.35509193 |
| 125 | AURKB | 0.35401028 |
| 126 | RET | 0.35067213 |
| 127 | LATS1 | 0.33249924 |
| 128 | CAMK2A | 0.33190740 |
| 129 | DAPK3 | 0.33044199 |
| 130 | DYRK1A | 0.32646135 |
| 131 | SRC | 0.31759831 |
| 132 | CAMKK1 | 0.30991069 |
| 133 | MST4 | 0.30555606 |
| 134 | EIF2AK2 | 0.30136995 |
| 135 | MET | 0.29923076 |
| 136 | FLT3 | 0.29262277 |
| 137 | PRKCB | 0.29253364 |
| 138 | PKN1 | 0.29052223 |
| 139 | CHEK1 | 0.28316287 |
| 140 | CDK6 | 0.28241453 |
| 141 | AKT2 | 0.28078964 |
| 142 | MAP2K3 | 0.27448392 |
| 143 | TRIB3 | 0.26994494 |
| 144 | PDGFRA | 0.26481612 |
| 145 | BRSK1 | 0.26411169 |
| 146 | CDK4 | 0.26304101 |
| 147 | ZAP70 | 0.26045058 |
| 148 | MAP3K1 | 0.25767818 |
| 149 | CSNK1D | 0.25521630 |
| 150 | BRD4 | 0.25187511 |
| 151 | MAPK8 | 0.24983036 |
| 152 | CDK1 | 0.23336698 |
| 153 | PRKACG | 0.23285487 |
| 154 | PIM1 | 0.23074490 |
| 155 | PRKCA | 0.21197787 |
| 156 | STK16 | 0.21057724 |
| 157 | MAPKAPK3 | 0.19901229 |
| 158 | MAPK14 | 0.19897555 |
| 159 | PRKDC | 0.19664668 |
| 160 | TTN | 0.19307000 |
| 161 | RIPK1 | 0.19069616 |
| 162 | PBK | 0.18000087 |
| 163 | PAK4 | 0.17384910 |
| 164 | GRK1 | 0.16725977 |
| 165 | PRKAA2 | 0.16723007 |
| 166 | SIK2 | 0.16641914 |
| 167 | SYK | 0.16167244 |
| 168 | FER | 0.15629187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Tyrosine metabolism_Homo sapiens_hsa00350 | 6.11599620 |
| 2 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 5.44704400 |
| 3 | Histidine metabolism_Homo sapiens_hsa00340 | 3.92898415 |
| 4 | Cocaine addiction_Homo sapiens_hsa05030 | 3.14025354 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.94500032 |
| 6 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.62426658 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.44053793 |
| 8 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.42965762 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.32891362 |
| 10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.26004008 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.25129599 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.24910593 |
| 13 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.20130282 |
| 14 | Proteasome_Homo sapiens_hsa03050 | 2.19777776 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.12614449 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.99765027 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.91452451 |
| 18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.77522908 |
| 19 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.72783473 |
| 20 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72137903 |
| 21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.71047138 |
| 22 | Base excision repair_Homo sapiens_hsa03410 | 1.69672110 |
| 23 | DNA replication_Homo sapiens_hsa03030 | 1.67330520 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.66207620 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.63671973 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.63668676 |
| 27 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.59483524 |
| 28 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.50961875 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.49673207 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.48800033 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.44190629 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43813787 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43721721 |
| 34 | Sulfur relay system_Homo sapiens_hsa04122 | 1.39620179 |
| 35 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.37792610 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.36369029 |
| 37 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.36114300 |
| 38 | Mismatch repair_Homo sapiens_hsa03430 | 1.35791796 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.34259797 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.32026142 |
| 41 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.29215590 |
| 42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.29082069 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26799879 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26691148 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.24957571 |
| 46 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.24550294 |
| 47 | Lysine degradation_Homo sapiens_hsa00310 | 1.24518351 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.20301200 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18878125 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 1.16740755 |
| 51 | Huntingtons disease_Homo sapiens_hsa05016 | 1.15957139 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.15294560 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.14524453 |
| 54 | Homologous recombination_Homo sapiens_hsa03440 | 1.14323316 |
| 55 | Olfactory transduction_Homo sapiens_hsa04740 | 1.13791789 |
| 56 | Long-term depression_Homo sapiens_hsa04730 | 1.12739579 |
| 57 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.11920267 |
| 58 | Circadian entrainment_Homo sapiens_hsa04713 | 1.11118013 |
| 59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.10292954 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 1.09371705 |
| 61 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.07423765 |
| 62 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.06167410 |
| 63 | RNA polymerase_Homo sapiens_hsa03020 | 1.06137832 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.06095943 |
| 65 | Insulin secretion_Homo sapiens_hsa04911 | 1.03322624 |
| 66 | Salivary secretion_Homo sapiens_hsa04970 | 1.02286503 |
| 67 | RNA transport_Homo sapiens_hsa03013 | 0.96779415 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.96248505 |
| 69 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.94444203 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94278562 |
| 71 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91999026 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.91907965 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.90972149 |
| 74 | Alcoholism_Homo sapiens_hsa05034 | 0.90886364 |
| 75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89966167 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86861107 |
| 77 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.86496893 |
| 78 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86295558 |
| 79 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.85676935 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84068581 |
| 81 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83906956 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82464587 |
| 83 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.82104707 |
| 84 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.80893191 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.80857020 |
| 86 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79962832 |
| 87 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.79795394 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76611298 |
| 89 | Taste transduction_Homo sapiens_hsa04742 | 0.75309093 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.75188424 |
| 91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.71076827 |
| 92 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.70025151 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69470520 |
| 94 | Ribosome_Homo sapiens_hsa03010 | 0.67044469 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66890740 |
| 96 | Cell cycle_Homo sapiens_hsa04110 | 0.66476548 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.66289710 |
| 98 | Long-term potentiation_Homo sapiens_hsa04720 | 0.65523164 |
| 99 | Spliceosome_Homo sapiens_hsa03040 | 0.65497175 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65227990 |
| 101 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.64727596 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64362136 |
| 103 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.63808109 |
| 104 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.61790436 |
| 105 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.61362176 |
| 106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61153537 |
| 107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60887127 |
| 108 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60880861 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.60193511 |
| 110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58721575 |
| 111 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57819755 |
| 112 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55830769 |
| 113 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55302917 |
| 114 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55157359 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53273665 |
| 116 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52522384 |
| 117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51360738 |
| 118 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.51347097 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48858463 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48419899 |
| 121 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.48361709 |
| 122 | Melanogenesis_Homo sapiens_hsa04916 | 0.47741892 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.45852646 |
| 124 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45809526 |
| 125 | Basal transcription factors_Homo sapiens_hsa03022 | 0.44742710 |
| 126 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44372651 |
| 127 | Axon guidance_Homo sapiens_hsa04360 | 0.43757854 |
| 128 | GABAergic synapse_Homo sapiens_hsa04727 | 0.41993104 |
| 129 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41846087 |
| 130 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40671987 |
| 131 | Amoebiasis_Homo sapiens_hsa05146 | 0.39012917 |
| 132 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37465651 |
| 133 | Platelet activation_Homo sapiens_hsa04611 | 0.36996171 |
| 134 | Morphine addiction_Homo sapiens_hsa05032 | 0.36156163 |
| 135 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35983635 |
| 136 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35842419 |
| 137 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34939550 |
| 138 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.34674698 |
| 139 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.34507914 |
| 140 | Purine metabolism_Homo sapiens_hsa00230 | 0.33621680 |
| 141 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33555848 |
| 142 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33127958 |
| 143 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.31845201 |
| 144 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.31327601 |
| 145 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30789188 |
| 146 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30664218 |
| 147 | Mineral absorption_Homo sapiens_hsa04978 | 0.30031908 |
| 148 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.28166736 |
| 149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27723530 |
| 150 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26663768 |
| 151 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.26648709 |
| 152 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.26527548 |
| 153 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25579070 |
| 154 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24967243 |
| 155 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.24704588 |
| 156 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24449131 |
| 157 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.22668480 |
| 158 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.22459999 |
| 159 | RNA degradation_Homo sapiens_hsa03018 | 0.21610642 |
| 160 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.21541708 |
| 161 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21141312 |
| 162 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.20849118 |
| 163 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20675823 |
| 164 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18602896 |
| 165 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.18198110 |
| 166 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.16139756 |
| 167 | Phototransduction_Homo sapiens_hsa04744 | 0.15965403 |
| 168 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.15949019 |
| 169 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.15746226 |

